- Home
- PLX vs VIRC Comparison
PLX vs VIRC Comparison
Compare PLX & VIRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLX
- VIRC
- Stock Information
- Founded
- PLX 1993
- VIRC 1950
- Country
- PLX Israel
- VIRC United States
- Employees
- PLX N/A
- VIRC N/A
- Industry
- PLX Biotechnology: Biological Products (No Diagnostic Substances)
- VIRC Industrial Specialties
- Sector
- PLX Health Care
- VIRC Consumer Discretionary
- Exchange
- PLX Nasdaq
- VIRC Nasdaq
- Market Cap
- PLX 160.2M
- VIRC 158.2M
- IPO Year
- PLX 1998
- VIRC N/A
- Fundamental
- Price
- PLX $2.59
- VIRC $9.38
- Analyst Decision
- PLX Strong Buy
- VIRC Buy
- Analyst Count
- PLX 1
- VIRC 1
- Target Price
- PLX $15.00
- VIRC $19.00
- AVG Volume (30 Days)
- PLX 764.3K
- VIRC 61.8K
- Earning Date
- PLX 03-17-2025
- VIRC 04-15-2025
- Dividend Yield
- PLX N/A
- VIRC 1.07%
- EPS Growth
- PLX N/A
- VIRC N/A
- EPS
- PLX 0.04
- VIRC 1.53
- Revenue
- PLX $53,399,000.00
- VIRC $280,375,000.00
- Revenue This Year
- PLX $67.17
- VIRC $6.43
- Revenue Next Year
- PLX $55.31
- VIRC $2.38
- P/E Ratio
- PLX $71.07
- VIRC $6.13
- Revenue Growth
- PLX N/A
- VIRC 5.68
- 52 Week Low
- PLX $0.82
- VIRC $9.08
- 52 Week High
- PLX $2.76
- VIRC $18.50
- Technical
- Relative Strength Index (RSI)
- PLX 58.97
- VIRC 34.74
- Support Level
- PLX $2.43
- VIRC $9.28
- Resistance Level
- PLX $2.62
- VIRC $9.63
- Average True Range (ATR)
- PLX 0.14
- VIRC 0.29
- MACD
- PLX 0.02
- VIRC -0.00
- Stochastic Oscillator
- PLX 85.00
- VIRC 9.71
About PLX Protalix BioTherapeutics Inc. (DE)
Protalix BioTherapeutics Inc is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system or ProCellEx. It has developed taliglucerase alfa for the treatment of Gaucher disease. The company's products also treat diseases like Fabry disease and cystic fibrosis. The company's primary sources of revenue include its sales of BioManguinhos alfataliglicerase in Brazil and of drug substances to Pfizer under its Amended Pfizer Agreement. The company's pipeline consists of ELFABRIO, Uricase, and Long Acting DNase I.
About VIRC Virco Manufacturing Corporation
Virco Manufacturing Corp is engaged in designing, production and distributing quality furniture for the commercial and education markets. The company manufactures an assortment of products, including mobile tables, mobile storage equipment, desks, computer furniture, chairs, and activity tables, folding chairs, and folding tables. Its primary furniture lines are constructed of tubular metal legs and frames, combined with wood and plastic tops, plastic seats and backs, upholstered seats and backs, and upholstered rigid polyethylene and polypropylene shells.